Contact
searchSearch
HMP Global

Volume 19 - Issue 4 - April, 2007

Feature
Catheter-Induced Left Main Coronary Artery Dissection Resulting in Abrupt Closure and Cardiac Arrest: Successful Stenting during
08/01/2008
J INVASIVE CARDIOL 2007;19:E93-E95 Left main coronary artery (LMCA) dissection is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI). LMCA dissection is the harbinger of catastrophic vessel...
J INVASIVE CARDIOL 2007;19:E93-E95 Left main coronary artery (LMCA) dissection is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI). LMCA dissection is the harbinger of catastrophic vessel...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology

Feature

Case Report
Catheter-Induced Left Main Coronary Artery Dissection Resulting in Abrupt Closure and Cardiac Arrest: Successful Stenting during
08/01/2008
Left main coronary artery (LMCA) dissection is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI). LMCA dissection is the harbinger of catastrophic vessel closure. It can be precipitated by the...
Left main coronary artery (LMCA) dissection is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI). LMCA dissection is the harbinger of catastrophic vessel closure. It can be precipitated by the...
Left main coronary artery (LMCA)...
08/01/2008
Journal of Invasive Cardiology
Case Report
Late Stent Thrombosis Associated with Coronary Aneurysm Formation after Sirolimus-Eluting Stent Implantation
08/01/2008
J INVASIVE CARDIOL 2007;19:E96-E98 Drug-eluting stents (DES) have been shown to be superior to bare-metal stents (BMS) in reducing the need for repeat revascularization.1 Their use has increased rapidly with DES accounting for up to 80% of...
J INVASIVE CARDIOL 2007;19:E96-E98 Drug-eluting stents (DES) have been shown to be superior to bare-metal stents (BMS) in reducing the need for repeat revascularization.1 Their use has increased rapidly with DES accounting for up to 80% of...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology
Case Report
Complete Cypher‚Ñ¢ Stent Fracture and Migration in the Ostium of the Right Coronary Artery
08/01/2008
J INVASIVE CARDIOL 2007;19:E99-E101 Stent fracture has been reported with the Cypher™ sirolimus-eluting stent (Cordis Corp., Miami, Florida) in 4 patients since the introduction of drug-eluting stents in 2004.1,2 In all of these cases, the...
J INVASIVE CARDIOL 2007;19:E99-E101 Stent fracture has been reported with the Cypher™ sirolimus-eluting stent (Cordis Corp., Miami, Florida) in 4 patients since the introduction of drug-eluting stents in 2004.1,2 In all of these cases, the...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology
Case Report
Single Coronary Artery from Right Aortic Sinus with Septal Course of Left Anterior Descending Artery and Left circumflex Artery
08/01/2008
J INVASIVE CARDIOL 2007;19:E102-E103 The occurrence of a single coronary artery (SCA) in structurally normal heart is uncommon. This anomaly is often clinically benign and presents as an incidental finding during coronary angiography....
J INVASIVE CARDIOL 2007;19:E102-E103 The occurrence of a single coronary artery (SCA) in structurally normal heart is uncommon. This anomaly is often clinically benign and presents as an incidental finding during coronary angiography....
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology
Case Report
A Novel Method of Clot Extraction Using a FilterWire EX‚Ñ¢ in Acute Myocardial Infarction
08/01/2008
J INVASIVE CARDIOL 2007;19:E104-E106 Acute myocardial infarction (MI) usually results from clot formation due to plaque rupture, platelet aggregation, and activation of the coagulation cascade.1,2 Contemporary therapy for acute MI involves...
J INVASIVE CARDIOL 2007;19:E104-E106 Acute myocardial infarction (MI) usually results from clot formation due to plaque rupture, platelet aggregation, and activation of the coagulation cascade.1,2 Contemporary therapy for acute MI involves...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology
Case Report
Extreme Coronary Guide Catheter Support: A Case of a Novel Telescopic Guide Catheter System with a Contralateral Aortic Wall Sup
08/01/2008
J INVASIVE CARDIOL 2007;19:E107-E110 Severe calcification and/or tortuosity of the coronary artery decrease the success of percutaneous coronary intervention (PCI). In such cases, adequate support of the guide catheter is of paramount...
J INVASIVE CARDIOL 2007;19:E107-E110 Severe calcification and/or tortuosity of the coronary artery decrease the success of percutaneous coronary intervention (PCI). In such cases, adequate support of the guide catheter is of paramount...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology
Case Report
Featured Case: Spontaneous Multivessel Coronary Vasospasm Leading to Cardiogenic Shock
08/01/2008
J INVASIVE CARDIOL 2007;19:E85-E88 Coronary vasospasm is a well-known cause of exercise-induced angina pectoris, Prinzmetal’s unstable angina, and myocardial infarction.1–6 In general, the prognosis of patients with isolated coronary...
J INVASIVE CARDIOL 2007;19:E85-E88 Coronary vasospasm is a well-known cause of exercise-induced angina pectoris, Prinzmetal’s unstable angina, and myocardial infarction.1–6 In general, the prognosis of patients with isolated coronary...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology
Case Report
Methamphetamine-Associated Acute Myocardial Infarction and Cardiogenic Shock with Normal Coronary Arteries: Refractory Global Co
08/01/2008
J INVASIVE CARDIOL 2007;19:E89-E92 Case Report. A 19-year-old male college student was admitted with 2 days of progressive, intermittent substernal chest pain. He had driven home from his out-of-state campus, where 2 days earlier he had...
J INVASIVE CARDIOL 2007;19:E89-E92 Case Report. A 19-year-old male college student was admitted with 2 days of progressive, intermittent substernal chest pain. He had driven home from his out-of-state campus, where 2 days earlier he had...
J INVASIVE CARDIOL...
08/01/2008
Journal of Invasive Cardiology

Column

Editorial Message
Apr-07
08/01/2008
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, commentary, letters to the editor, articles from our Rapid Communication and Clinical Images sections, and online case reports, as well as...
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, commentary, letters to the editor, articles from our Rapid Communication and Clinical Images sections, and online case reports, as well as...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology

News

AHA Scientific Statement
New American Heart Association Scientific Statement on Pulmonary Embolism Management & Outcomes
03/21/2025
A new scientific statement from the American Heart Association, Disparities in Current Pulmonary Embolism Management and Outcomes, summarizes differences in diagnosis, treatment strategies and long-term outcomes related to PE.
A new scientific statement from the American Heart Association, Disparities in Current Pulmonary Embolism Management and Outcomes, summarizes differences in diagnosis, treatment strategies and long-term outcomes related to PE.
A new scientific statement from...
03/21/2025
Cath Lab Digest
Therapeutics
Alnylam Announces FDA Approval of Amvuttra (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)
03/21/2025
The approval expands the indication for AMVUTTRA, which now becomes the first and only therapeutic approved by the FDA for the treatment of ATTR-CM and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
The approval expands the indication for AMVUTTRA, which now becomes the first and only therapeutic approved by the FDA for the treatment of ATTR-CM and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
The approval expands the...
03/21/2025
Cath Lab Digest
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
SCAI
JSCAI Special Issue Explores the Transformative Role of Artificial Intelligence in Interventional Cardiology
03/18/2025
"AI is now an integral part of our daily lives, whether we are prepared for it or not. In medicine, particularly in interventional cardiology, its impact is profound,” said guest editor Elazer R. Edelman, MD, PhD.
"AI is now an integral part of our daily lives, whether we are prepared for it or not. In medicine, particularly in interventional cardiology, its impact is profound,” said guest editor Elazer R. Edelman, MD, PhD.
"AI is now an integral part of...
03/18/2025
Cath Lab Digest
Acquisitions
Ostial Corporation Becomes Verge Medical Following Strategic Acquisition
03/17/2025
Ostial Corporation, focused on addressing the clinical challenges of aorto-ostial interventions, announced the acquisition of the Wavella™ technology from Crossfire Medical. The company also unveiled its new identity as Verge Medical.
Ostial Corporation, focused on addressing the clinical challenges of aorto-ostial interventions, announced the acquisition of the Wavella™ technology from Crossfire Medical. The company also unveiled its new identity as Verge Medical.
Ostial Corporation, focused on...
03/17/2025
Cath Lab Digest
AltiX AI.i ComboLab
AI
GE HealthCare Expands Invasive Cardiology Portfolio With AltiX AI.i for Cath Lab and EP Procedures 
03/17/2025
The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features...
The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features...
The AltiX AI.i editions are...
03/17/2025
Cath Lab Digest
Heart Formation
New Hope for Heart Disease: Unlocking How the Heart Forms Before Birth
03/17/2025
Dr. Mingfu Wu and his team's findings, published in Science, focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.
Dr. Mingfu Wu and his team's findings, published in Science, focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.
Dr. Mingfu Wu and his team's...
03/17/2025
Cath Lab Digest
Out-of-Hospital Cardiac Arrest
ESC: Resuscitation in Out-of-Hospital Cardiac Arrest – It’s How Quickly It Is Done, Rather Than Who Does It
03/17/2025
The fact that 80% of out-of-hospital cardiac arrests (OHCA) occur in residential settings highlights the crucial need for further public education and Basic Life Support (BLS) training to improve survival rates.
The fact that 80% of out-of-hospital cardiac arrests (OHCA) occur in residential settings highlights the crucial need for further public education and Basic Life Support (BLS) training to improve survival rates.
The fact that 80% of...
03/17/2025
Cath Lab Digest
Heart Failure
U.S. FDA Accepts Supplemental New Drug Application Under Priority Review for New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40%
03/17/2025
KERENDIA® (finerenone) is the first non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA) to meet a primary cardiovascular (CV) endpoint in a Phase III study investigating patients with heart failure (HF) with mildly reduced...
KERENDIA® (finerenone) is the first non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA) to meet a primary cardiovascular (CV) endpoint in a Phase III study investigating patients with heart failure (HF) with mildly reduced...
KERENDIA® (finerenone) is the...
03/17/2025
Cath Lab Digest
CAD Diagnosis: AI
Caristo Diagnostics Receives U.S. FDA 510(k) Clearance of CaRi-Plaque Technology, an AI-assisted Image Analysis Application to Aid the Diagnosis of Coronary Artery Disease (CAD)
03/13/2025
CaRi-Plaque builds on Caristo’s breakthrough core CaRi-Heart® technology, which a landmark Lancet 2024 study proved can reveal hidden, high-risk markers of CAD progression — predicting heart attacks up to a decade before they strike.
CaRi-Plaque builds on Caristo’s breakthrough core CaRi-Heart® technology, which a landmark Lancet 2024 study proved can reveal hidden, high-risk markers of CAD progression — predicting heart attacks up to a decade before they strike.
CaRi-Plaque builds on Caristo’s...
03/13/2025
Cath Lab Digest

Endologix Announces 1000 Patients Treated With the DETOUR System
03/21/2025
Percutaneous Transmural Arterial Bypass (PTAB) with the DETOUR System offers a novel approach to treating complex PAD, enabling physicians to percutaneously bypass lesions in the superficial femoral artery by using stents routed through the...
Percutaneous Transmural Arterial Bypass (PTAB) with the DETOUR System offers a novel approach to treating complex PAD, enabling physicians to percutaneously bypass lesions in the superficial femoral artery by using stents routed through the...
Percutaneous Transmural Arterial...
03/21/2025
Cath Lab Digest
AHA Scientific Statement
New American Heart Association Scientific Statement on Pulmonary Embolism Management & Outcomes
03/21/2025
A new scientific statement from the American Heart Association, Disparities in Current Pulmonary Embolism Management and Outcomes, summarizes differences in diagnosis, treatment strategies and long-term outcomes related to PE.
A new scientific statement from the American Heart Association, Disparities in Current Pulmonary Embolism Management and Outcomes, summarizes differences in diagnosis, treatment strategies and long-term outcomes related to PE.
A new scientific statement from...
03/21/2025
Cath Lab Digest
Therapeutics
Alnylam Announces FDA Approval of Amvuttra (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)
03/21/2025
The approval expands the indication for AMVUTTRA, which now becomes the first and only therapeutic approved by the FDA for the treatment of ATTR-CM and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
The approval expands the indication for AMVUTTRA, which now becomes the first and only therapeutic approved by the FDA for the treatment of ATTR-CM and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
The approval expands the...
03/21/2025
Cath Lab Digest
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
SCAI
JSCAI Special Issue Explores the Transformative Role of Artificial Intelligence in Interventional Cardiology
03/18/2025
"AI is now an integral part of our daily lives, whether we are prepared for it or not. In medicine, particularly in interventional cardiology, its impact is profound,” said guest editor Elazer R. Edelman, MD, PhD.
"AI is now an integral part of our daily lives, whether we are prepared for it or not. In medicine, particularly in interventional cardiology, its impact is profound,” said guest editor Elazer R. Edelman, MD, PhD.
"AI is now an integral part of...
03/18/2025
Cath Lab Digest
ES image
CRT Conference Coverage
Future Direction for RDN: From Hypertension to AFib and Beyond
03/18/2025
In this video from CRT 2025, JIC speaks with Dr Eric Secemsky of the Beth Israel Deaconness Medical Center about the future of renal denervation in atrial fibrillation treatment.
In this video from CRT 2025, JIC speaks with Dr Eric Secemsky of the Beth Israel Deaconness Medical Center about the future of renal denervation in atrial fibrillation treatment.
In this video from CRT 2025, JIC...
03/18/2025
Journal of Invasive Cardiology
Acquisitions
Ostial Corporation Becomes Verge Medical Following Strategic Acquisition
03/17/2025
Ostial Corporation, focused on addressing the clinical challenges of aorto-ostial interventions, announced the acquisition of the Wavella™ technology from Crossfire Medical. The company also unveiled its new identity as Verge Medical.
Ostial Corporation, focused on addressing the clinical challenges of aorto-ostial interventions, announced the acquisition of the Wavella™ technology from Crossfire Medical. The company also unveiled its new identity as Verge Medical.
Ostial Corporation, focused on...
03/17/2025
Cath Lab Digest
AltiX AI.i ComboLab
AI
GE HealthCare Expands Invasive Cardiology Portfolio With AltiX AI.i for Cath Lab and EP Procedures 
03/17/2025
The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features...
The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features...
The AltiX AI.i editions are...
03/17/2025
Cath Lab Digest
Heart Formation
New Hope for Heart Disease: Unlocking How the Heart Forms Before Birth
03/17/2025
Dr. Mingfu Wu and his team's findings, published in Science, focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.
Dr. Mingfu Wu and his team's findings, published in Science, focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.
Dr. Mingfu Wu and his team's...
03/17/2025
Cath Lab Digest
Out-of-Hospital Cardiac Arrest
ESC: Resuscitation in Out-of-Hospital Cardiac Arrest – It’s How Quickly It Is Done, Rather Than Who Does It
03/17/2025
The fact that 80% of out-of-hospital cardiac arrests (OHCA) occur in residential settings highlights the crucial need for further public education and Basic Life Support (BLS) training to improve survival rates.
The fact that 80% of out-of-hospital cardiac arrests (OHCA) occur in residential settings highlights the crucial need for further public education and Basic Life Support (BLS) training to improve survival rates.
The fact that 80% of...
03/17/2025
Cath Lab Digest

April 2007 Volume 19 Issue 4

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use